Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children - PubMed (original) (raw)
Clinical Trial
Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children
N Simakachorn et al. J Pediatr Gastroenterol Nutr. 2000 Jan.
Erratum in
- J Pediatr Gastroenterol Nutr 2000 Feb;30(2):228
Abstract
Background: Addition of a medication to the World Health Organization protocol for treatment of acute diarrhea in children is controversial. In this trial, the clinical efficacy of a medication (Lactéol Fort sachets; Laboratoire du Lactéol du Docteur Boucard, Houdan France) containing lyophilized heat-killed Lactobacillus acidophilus LB was assessed as an adjunct to oral rehydration therapy.
Methods: Children aged 3 to 24 months with acute diarrhea and mild or moderate dehydration were enrolled in the study. Children received oral rehydration therapy for the first 4 hours. After this first rehydration phase, undiluted milk formula or breast milk was fed alternately with oral rehydration solution. Children were fed rice gruel as tolerated. They received either one sachet containing 10 billion of lyophilized heat-killed L. acidophilus LB or placebo at admission and at 12-hour intervals for five doses.
Results: Seventy-three children (37 L. acidophilus LB, 36 placebo) were enrolled, of whom 40 (17 L. acidophilus LB, 23 placebo) received an antibiotic before inclusion. Rotavirus was identified in approximately 50% of the children in each group. After 24 hours of treatment, the number of rotavirus-positive children with watery stools was significantly lower (p = 0.012) in the L. acidophilus LB group. Mean duration of diarrhea was decreased (p = 0.034) with L. acidophilus LB (43.4 hours) versus placebo (57.0 hours). This decreased duration was particularly marked in children with no antibiotic therapy before inclusion (31.1 hours): 42.9 hours for the L. acidophilus LB group versus 74.0 hours for the placebo group (p = 0.016).
Conclusions: Addition of L. acidophilus LB to oral rehydration therapy was effective in the treatment of children with acute diarrhea by decreasing the duration of diarrhea.
Similar articles
- An experimental study and a randomized, double-blind, placebo-controlled clinical trial to evaluate the antisecretory activity of Lactobacillus acidophilus strain LB against nonrotavirus diarrhea.
Liévin-Le Moal V, Sarrazin-Davila LE, Servin AL. Liévin-Le Moal V, et al. Pediatrics. 2007 Oct;120(4):e795-803. doi: 10.1542/peds.2006-2930. Epub 2007 Sep 3. Pediatrics. 2007. PMID: 17768180 Clinical Trial. - Effectiveness and safety of Lactobacillus LB in the treatment of mild acute diarrhea in children.
Salazar-Lindo E, Figueroa-Quintanilla D, Caciano MI, Reto-Valiente V, Chauviere G, Colin P; Lacteol Study Group. Salazar-Lindo E, et al. J Pediatr Gastroenterol Nutr. 2007 May;44(5):571-6. doi: 10.1097/MPG.0b013e3180375594. J Pediatr Gastroenterol Nutr. 2007. PMID: 17460488 Clinical Trial. - Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial.
Guandalini S, Pensabene L, Zikri MA, Dias JA, Casali LG, Hoekstra H, Kolacek S, Massar K, Micetic-Turk D, Papadopoulou A, de Sousa JS, Sandhu B, Szajewska H, Weizman Z. Guandalini S, et al. J Pediatr Gastroenterol Nutr. 2000 Jan;30(1):54-60. doi: 10.1097/00005176-200001000-00018. J Pediatr Gastroenterol Nutr. 2000. PMID: 10630440 Clinical Trial. - Chinese clinical practice guidelines for acute infectious diarrhea in children.
Chen J, Wan CM, Gong ST, Fang F, Sun M, Qian Y, Huang Y, Wang BX, Xu CD, Ye LY, Dong M, Jin Y, Huang ZH, Wu QB, Zhu CM, Fang YH, Zhu QR, Dong YS. Chen J, et al. World J Pediatr. 2018 Oct;14(5):429-436. doi: 10.1007/s12519-018-0190-2. Epub 2018 Sep 29. World J Pediatr. 2018. PMID: 30269306 Review. - Rice-based oral rehydration solution for treating diarrhoea.
Fontaine O, Gore SM, Pierce NF. Fontaine O, et al. Cochrane Database Syst Rev. 2000;(2):CD001264. doi: 10.1002/14651858.CD001264. Cochrane Database Syst Rev. 2000. PMID: 10796624 Updated. Review.
Cited by
- Postbiotics as Metabolites and Their Biotherapeutic Potential.
Hijová E. Hijová E. Int J Mol Sci. 2024 May 16;25(10):5441. doi: 10.3390/ijms25105441. Int J Mol Sci. 2024. PMID: 38791478 Free PMC article. Review. - In vitro evaluation of Lactiplantibacillus plantarum HOKKAIDO strain, effective lactic acid bacteria for calf diarrhea.
Ikehata M, Konnai S, Okagawa T, Abe K, Honma M, Kitamura T, Maekawa N, Suzuki Y, Murata S, Ohashi K. Ikehata M, et al. Front Vet Sci. 2023 Apr 5;10:1145445. doi: 10.3389/fvets.2023.1145445. eCollection 2023. Front Vet Sci. 2023. PMID: 37089407 Free PMC article. - The clinical evidence for postbiotics as microbial therapeutics.
Mosca A, Abreu Y Abreu AT, Gwee KA, Ianiro G, Tack J, Nguyen TVH, Hill C. Mosca A, et al. Gut Microbes. 2022 Jan-Dec;14(1):2117508. doi: 10.1080/19490976.2022.2117508. Gut Microbes. 2022. PMID: 36184735 Free PMC article. Review. - Postbiotics and Kidney Disease.
Favero C, Giordano L, Mihaila SM, Masereeuw R, Ortiz A, Sanchez-Niño MD. Favero C, et al. Toxins (Basel). 2022 Sep 6;14(9):623. doi: 10.3390/toxins14090623. Toxins (Basel). 2022. PMID: 36136562 Free PMC article. Review. - A Systematic Review and Meta-Analysis: Lactobacillus acidophilus for Treating Acute Gastroenteritis in Children.
Cheng H, Ma Y, Liu X, Tian C, Zhong X, Zhao L. Cheng H, et al. Nutrients. 2022 Feb 6;14(3):682. doi: 10.3390/nu14030682. Nutrients. 2022. PMID: 35277042 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical